Ethanol Extract of Pomegranate (
Journal
International journal of inflammation
ISSN: 2090-8040
Titre abrégé: Int J Inflam
Pays: United States
ID NLM: 101538188
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
09
2021
revised:
04
11
2021
accepted:
10
11
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
14
12
2021
Statut:
epublish
Résumé
Colorectal cancer (CRC) is a malignancy derived from the glandular epithelial cells in the colon. Patients with inflammatory bowel disease (IBD) are more likely to develop CRC. Cancer proliferation is characterized by the loss of inhibition of apoptosis, which involves caspase-3 activation. This study examined the effects of the pomegranate peel extract on the expression of caspase-3 in mice crypt cells induced by dextran sodium sulfate (DSS) 2%. The experimental study was done in six groups. All treatments were done in 42 days. The groups were all induced by DSS through water drinking, except for the normal group, which was only given water. The treatments given included the pomegranate extract in two doses (240 mg and 480 mg/kg bw/day), aspirin, and ellagic acid. The specimens were then fixated and stained for the immunohistochemistry scoring for the expression of caspase-3, which was then analyzed statistically. The H-scores of each treatment group were 213.23 ± 8.32 (DSS group), 243.81 ± 18.69 (normal group), 226.10 ± 12.38 (pomegranate peel extract of 240 mg/kg/d), 238.84 ± 15.81 (pomegranate peel extract of 480 mg/kg/d), 227.47 ± 12.15 (aspirin), and 224.01 ± 18.39 (ellagic acid). Statistical differences were found in one-way analysis of variance (ANOVA) and The ethanol extract of pomegranate was able to induce apoptosis, which was demonstrated by the increase of caspase-3 expression.
Sections du résumé
BACKGROUND
BACKGROUND
Colorectal cancer (CRC) is a malignancy derived from the glandular epithelial cells in the colon. Patients with inflammatory bowel disease (IBD) are more likely to develop CRC. Cancer proliferation is characterized by the loss of inhibition of apoptosis, which involves caspase-3 activation. This study examined the effects of the pomegranate peel extract on the expression of caspase-3 in mice crypt cells induced by dextran sodium sulfate (DSS) 2%.
METHODS
METHODS
The experimental study was done in six groups. All treatments were done in 42 days. The groups were all induced by DSS through water drinking, except for the normal group, which was only given water. The treatments given included the pomegranate extract in two doses (240 mg and 480 mg/kg bw/day), aspirin, and ellagic acid. The specimens were then fixated and stained for the immunohistochemistry scoring for the expression of caspase-3, which was then analyzed statistically.
RESULTS
RESULTS
The H-scores of each treatment group were 213.23 ± 8.32 (DSS group), 243.81 ± 18.69 (normal group), 226.10 ± 12.38 (pomegranate peel extract of 240 mg/kg/d), 238.84 ± 15.81 (pomegranate peel extract of 480 mg/kg/d), 227.47 ± 12.15 (aspirin), and 224.01 ± 18.39 (ellagic acid). Statistical differences were found in one-way analysis of variance (ANOVA) and
CONCLUSIONS
CONCLUSIONS
The ethanol extract of pomegranate was able to induce apoptosis, which was demonstrated by the increase of caspase-3 expression.
Identifiants
pubmed: 34900217
doi: 10.1155/2021/4919410
pmc: PMC8660243
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4919410Informations de copyright
Copyright © 2021 Kusmardi Kusmardi et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Med Food. 2014 Mar;17(3):339-49
pubmed: 24650251
Mol Med Rep. 2013 Mar;7(3):909-14
pubmed: 23292806
Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G7-17
pubmed: 15194558
Asian Pac J Cancer Prev. 2018 May 26;19(5):1277-1280
pubmed: 29801534
Cell Death Dis. 2013 May 02;4:e613
pubmed: 23640455
Prz Gastroenterol. 2019;14(2):89-103
pubmed: 31616522
Biomed Pharmacother. 2017 Sep;93:976-984
pubmed: 28724216
Anticancer Res. 2005 Mar-Apr;25(2A):971-9
pubmed: 15868936
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Nutr Cancer. 2016;68(1):120-30
pubmed: 26699876
ScientificWorldJournal. 2016;2016:8626987
pubmed: 27668280
Int J Mol Sci. 2019 May 17;20(10):
pubmed: 31108984
Molecules. 2017 Jan 24;22(1):
pubmed: 28125044
World J Gastroenterol. 2008 Jul 14;14(26):4227-33
pubmed: 18636671
Adv Pharm Bull. 2014 Dec;4(Suppl 2):583-90
pubmed: 25671193
Intest Res. 2014 Jul;12(3):194-204
pubmed: 25349593
Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):461-72
pubmed: 22122763
Curr Protoc Immunol. 2014 Feb 04;104:15.25.1-15.25.14
pubmed: 24510619
Oxid Med Cell Longev. 2015;2015:938475
pubmed: 26180600
Caspian J Intern Med. 2017 Summer;8(3):226-227
pubmed: 28932378
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Iran J Pharm Res. 2012 Spring;11(2):385-400
pubmed: 24250463
Therap Adv Gastroenterol. 2011 Jul;4(4):237-48
pubmed: 21765868
Future Virol. 2017 Mar;13(4):287-305
pubmed: 29937918
Methods Mol Biol. 2016;1422:297-307
pubmed: 27246042
Biomed Res Int. 2015;2015:219670
pubmed: 25654088